Phenotyping via eosinophils may help identify which patients with COPD exacerbations are most likely to have a favourable risk/benefit ratio for inhaled corticosteroids and those who will not. However a sizeable grey area remains in between, the Respiratory Insights Forum in Melbourne was told. Dr James Chalmers, from the University of Dundee in Scotland, said ...
Eosinophils worth checking in COPD exacerbations
Sponsored by A. Menarini Pty Ltd
9 Nov 2017